Literature DB >> 2081479

Aetiology and pathophysiology of chronic liver disorders.

J Schölmerich1, A Holstege.   

Abstract

The aetiology of chronic liver disease covers a wide range of congenital or acquired abnormalities of the hepatocellular biochemical network. Although our knowledge has considerably increased in recent years, the aetiology of chronic liver disease often remains obscure. Acquired irreversible disturbances of normal liver function can be mediated by hepatotrophic viruses, chemicals, chronic oxygen depletion, or interference with the immune system. Considerable progress has been made in the detection and characterisation of hepatitis B, C, and D viruses as causative agents of chronic active hepatitis. Alcohol abuse remains the predominant cause of chronic liver disease in the Western world. The targets of autoantibodies used to diagnose autoimmune diseases of the liver and primary biliary cirrhosis continue to be biochemically defined. Their significance for the aetiology of the disease, however, remains to be established. Nonparenchymal cells play an important role in the sequence of events following hepatocellular injury and ultimately leading to liver cirrhosis. They release vasoactive compounds, cytokines, and other important mediators, and participate in the modulation of the extracellular matrix that is characteristic of liver fibrosis and cirrhosis. The biochemical basis of liver cell necrosis remains poorly defined. In spite of recent progress, and the detection of some new pathogenic principles that help in the understanding of the complications of chronic liver disease such as portal hypertension, oesophagogastric variceal bleeding, portosystemic encephalopathy, ascites, and other metabolic disturbances, many questions concerning the aetiology and pathophysiology of chronic liver disease and its complications remain to be answered.

Entities:  

Mesh:

Year:  1990        PMID: 2081479     DOI: 10.2165/00003495-199000403-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  152 in total

1.  Reactivity of primary biliary cirrhosis sera with a human fetal liver cDNA clone of branched-chain alpha-keto acid dehydrogenase dihydrolipoamide acyltransferase, the 52 kD mitochondrial autoantigen.

Authors:  C D Surh; D J Danner; A Ahmed; R L Coppel; I R Mackay; E R Dickson; M E Gershwin
Journal:  Hepatology       Date:  1989-01       Impact factor: 17.425

Review 2.  [Changes in connective tissue metabolism in alcohol-induced liver fibrosis].

Authors:  D Schuppan; E G Hahn; E O Riecken
Journal:  Z Gastroenterol       Date:  1988-10       Impact factor: 2.000

3.  [Delta hepatitis].

Authors:  M Rizzetto; G Verme
Journal:  Internist (Berl)       Date:  1985-10       Impact factor: 0.743

4.  Is ascites caused by impaired hepatic inactivation of blood borne endogenous opioid peptides?

Authors:  J R Thornton; H Dean; M S Losowsky
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

5.  Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis.

Authors:  B A Runyon
Journal:  Hepatology       Date:  1988 May-Jun       Impact factor: 17.425

6.  Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

Authors:  U M Zanger; H P Hauri; J Loeper; J C Homberg; U A Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

8.  Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.

Authors:  R W Chapman; M Cottone; W S Selby; H A Shepherd; S Sherlock; D P Jewell
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

9.  Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency.

Authors:  S Eriksson; J Carlson; R Velez
Journal:  N Engl J Med       Date:  1986-03-20       Impact factor: 91.245

Review 10.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

View more
  1 in total

1.  Glutamine synthetase activity and glutamate uptake in hippocampus and frontal cortex in portal hypertensive rats.

Authors:  Gabriela Beatriz Acosta; María Alejandra Fernández; Diego Martín Roselló; María Luján Tomaro; Karina Balestrasse; Abraham Lemberg
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.